Shattuck Labs: Priced As If Risk Was Not A Part Of The Equation

Shattuck Labs pivots from oncology to autoimmune diseases after pipeline failure, now relying on early-stage asset SL-325 ...
ALS News Today

Neurizon gets OK to test liquid form of ALS medication in Australia

Neurizon received approval for a Phase 1 trial of liquid NUZ-001 for ALS in Australia. This liquid form addresses swallowing difficulties common in ALS patients. NUZ-001 aims to restore autophagy, ...

Prairie Lithium starts final testing of commercial-scale DLE unit ahead of Saskatchewan deployment

Prairie Lithium Ltd (ASX:PL9, OTC:PLIXF, FRA:PLIX) has started Factory Acceptance Testing (FAT) of its commercial-scale ...
Nasdaq

HPQ’s Latest Pilot Test Delivers Higher-Purity, Higher-Quality Fumed Silica While Validating Semi-Continuous Reactor Operation

Material analysis conducted by the Leading Global Fumed Silica Manufacturer (LGFSM) confirmed several notable improvements in the fumed silica produced during Phase 1 Test #5 compared to Test #4: With ...
National Academies of Sciences%2c Engineering%2c and Medicine

Testing of Body Armor Materials: Phase III

During Phases I and II of the study, the committee was requested to consider the use of statistics to permit a more scientific determination of sample sizes to be used in body armor testing.
The Scientist

FDA Announces Plan to Phase Out Animal Testing. Will That Work?

In April of this year, the Food and Drug Administration (FDA) announced a new roadmap that aims to replace animal testing in the development of new drugs with more human-relevant methods. The goal is ...